by
Gus Iversen, Editor in Chief | March 21, 2025
GE HealthCare's Invenia ABUS Premium at ECR 2025
GE HealthCare has launched the Invenia automated breast ultrasound (ABUS) Premium, an advanced 3D ultrasound system designed to improve breast cancer detection in patients with dense breast tissue.
The system integrates AI to enhance scan efficiency and image quality, aiming to assist clinicians in identifying malignancies that may be missed by traditional mammography.
Dense breast tissue can obscure cancer on mammograms, contributing to later-stage diagnoses. Research indicates that about 40% of women in the U.S. and Europe — and up to 70% in some Asian populations — have dense breasts, which increases their risk of developing breast cancer. Supplemental screening methods like ABUS have been shown to improve detection rates in these cases.
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
The Invenia ABUS Premium incorporates GE HealthCare’s new Verisound AI tools, including Scan Quality Assessment for real-time evaluation and Auto Nipple Detection to standardize imaging. A new Fast Scan feature is designed to reduce scan times by up to 40%.
Additionally, its cSound Imageformer technology optimizes image resolution and consistency, while the Reverse Curve transducer is designed to contour to breast anatomy for patient comfort.
The system includes the Invenia ABUS Viewer with AI Assistant, allowing physicians to review and interpret exams remotely. AI-powered tools assist in identifying and characterizing breast lesions, potentially improving efficiency and addressing staffing shortages.
“The new Reverse Curve transducer makes the examination more patient-friendly and comfortable," noted Dr. Athina Vourtsis, chief director and founder of Athena Medical in Greece. "There has been great improvement in image quality with less shadowing, and the structures behind the nipple are seen more clearly, providing radiologists with greater diagnostic confidence.”
GE HealthCare has received Premarket Approval (PMA) from the FDA for the Invenia ABUS Premium, with plans for international rollout in 2025. The system was featured at the 2025 European Congress of Radiology and will be showcased at upcoming industry events.
